Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
Science Translational Medicine, 2020
Abstract
PolyQ ATXN3 is a pharmacodynamic marker for SCA3, and a SNP associated with the expanded allele may serve to specifically target mutant ATXN3 .
cristina Januario hasn't uploaded this paper.
Let cristina know you want this paper to be uploaded.
Ask for this paper to be uploaded.